Acquisition of vancomycin-resistant enterococci in internal medicine wards

American Journal of Infection Control

Volumn 37, Issue 2, 2009, Pages 111-116

  Cohen, Matan J ^a   Adler, Amos ^a   Block, Colin ^a   Gross, Ilana ^a   Minster, Naomi ^a   Roval, Varda ^a   Tchakirov, Rachel ^a   Moses, Allon E ^a   Benenson, Shmuel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTEROCOCCAL INFECTION; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; VANCOMYCIN RESISTANT ENTEROCOCCUS; WARD;

AGED; AGED, 80 AND OVER; CARRIER STATE; CROSS INFECTION; CROSS-SECTIONAL STUDIES; ENTEROCOCCUS; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERINEUM; PREVALENCE;

EID: 63649109529     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2008.04.260     Document Type: Article

References (45)

1. Hayden M.K. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 31 (2000) 1058-1065
2. Zirakzadeh A., and Patel R. Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc 81 (2006) 529-536
3. Byers K.E., Anglim A.M., Anneski C.J., and Farr B.M. Duration of colonization with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 23 (2002) 207-211
4. Kramer A., Schwebke I., and Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6 (2006) 130
5. Neely A.N., and Maley M.P. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38 (2000) 724-726
6. Noskin G.A., Bednarz P., Suriano T., Reiner S., and Peterson L.R. Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: implications for upholstery selection in hospitals. Am J Infect Control 28 (2000) 311-313
7. Siegel J.D., Rhinehart E., Jackson M., and Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35 10 Suppl.2 (2007) S65-S164
8. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 23 (1995) 87-94
9. Muto C.A., Jernigan J.A., Ostrowsky B.E., Richet H.M., Jarvis W.R., Boyce J.M., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
10. Isenberg H.D. American Society for Microbiology. Clinical microbiology procedures handbook. 2nd ed. (2004), ASM Press, Washington, DC
11. Clinical and Laboratory Standards Institute. Standard M100-S16: performance standards for antimicrobial susceptibility testing. 16th informational supplement (2006), CLSI, Wayne (PA)
12. Murray B.E., Singh K.V., Heath J.D., Sharma B.R., and Weinstock G.M. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 28 (1990) 2059-2063
13. Turabelidze D., Kotetishvili M., Kreger A., Morris Jr. J.G., and Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 38 (2000) 4242-4245
14. Singh A., Goering R.V., Simjee S., Foley S.L., and Zervos M.J. Application of molecular techniques to the study of hospital infection. Clin Microbiol Rev 19 (2006) 512-530
15. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33 (1995) 2233-2239
16. Furuno J.P., Harris A.D., Wright M.O., McGregor J.C., Venezia R.A., Zhu J., et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 32 (2004) 436-440
17. Bhalla A., Pultz N.J., Gries D.M., Ray A.J., Eckstein E.C., Aron D.C., et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 25 (2004) 164-167
18. Ray A.J., Hoyen C.K., Taub T.F., Eckstein E.C., and Donskey C.J. Nosocomial transmission of vancomycin-resistant enterococci from surfaces. JAMA 287 (2002) 1400-1401
19. Randle J., Clarke M., and Storr J. Hand hygiene compliance in healthcare workers. J Hosp Infect 64 (2006) 205-209
20. Whitby M., McLaws M.L., and Ross M.W. Why healthcare workers don't wash their hands: a behavioral explanation. Infect Control Hosp Epidemiol 27 (2006) 484-492
21. Ostrowsky B.E., Trick W.E., Sohn A.H., Quirk S.B., Holt S., Carson L.A., et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 344 (2001) 1427-1433
22. Furuno J.P., McGregor J.C., Harris A.D., Johnson J.A., Johnson J.K., Langenberg P., et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 166 (2006) 580-585
23. Donskey C.J., Chowdhry T.K., Hecker M.T., Hoyen C.K., Hanrahan J.A., Hujer A.M., et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 343 (2000) 1925-1932
24. Fridkin S.K., Edwards J.R., Courval J.M., Hill H., Tenover F.C., Lawton R., et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 135 (2001) 175-183
25. Kolar M., Urbanek K., Vagnerova I., and Koukalova D. The influence of antibiotic use on the occurrence of vancomycin-resistant enterococci. J Clin Pharm Ther 31 (2006) 67-72
26. Trick W.E., Paule S.M., Cunningham S., Cordell R.L., Lankford M., Stosor V., et al. Detection of vancomycin-resistant enterococci before and after antimicrobial therapy: use of conventional culture and polymerase chain reaction. Clin Infect Dis 38 (2004) 780-786
27. Wells C.L., Juni B.A., Cameron S.B., Mason K.R., Dunn D.L., Ferrieri P., et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 21 (1995) 45-50
28. Gambarotto K., Ploy M.C., Turlure P., Grelaud C., Martin C., Bordessoule D., et al. Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France. J Clin Microbiol 38 (2000) 620-624
29. Kolar M., Pantucek R., Vagnerova I., Sauer P., Kesselova M., Cekanova L., et al. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. New Microbiol 29 (2006) 121-125
30. Padiglione A.A., Grabsch E., Wolfe R., Gibson K., and Grayson M.L. The prevalence of fecal colonization with VRE among residents of long-term-care facilities in Melbourne, Australia. Infect Control Hosp Epidemiol 22 (2001) 576-578
31. Elizaga M.L., Weinstein R.A., and Hayden M.K. Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci. Clin Infect Dis 34 (2002) 441-446
32. Balzereit-Scheuerlein F., and Stephan R. Prevalence of colonisation and resistance patterns of vancomycin-resistant enterococci in healthy, non-hospitalised persons in Switzerland. Swiss Med Wkly 131 (2001) 280-282
33. Padiglione A.A., Wolfe R., Grabsch E.A., Olden D., Pearson S., Franklin C., et al. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 47 (2003) 2492-2498
34. Puzniak L.A., Gillespie K.N., Leet T., Kollef M., and Mundy L.M. A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?. Infect Control Hosp Epidemiol 25 (2004) 418-424
35. Chazan B., Sakran W., Raz R., and Colodner R. Improved antimicrobial susceptibility of community-acquired uropathogens in northern Israel (1995-1999-2002). Int J Antimicrob Agents 24 (2004) 89-92
36. Marcus N., Peled N., and Yagupsky P. Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel. Eur J Clin Microbiol Infect Dis 16 (1997) 913-915
37. Dan M., Poch F., Leibson L., Smetana S., and Priel I. Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J Hosp Infect 43 (1999) 231-238
38. Toledano H., Schlesinger Y., Raveh D., Rudensky B., Attias D., Eidelman A.I., et al. Prospective surveillance of vancomycin-resistant enterococci in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 19 (2000) 282-287
39. Cohen M.J., Anshelevich O., Raveh D., Broide E., Rudensky B., and Yinnon A.M. Acquisition of multidrug-resistant organisms among hospital patients hospitalized in beds adjacent to critically ill patients. Infect Control Hosp Epidemiol 27 (2006) 675-681
40. Willems R.J., Top J., van Santen M., Robinson D.A., Coque T.M., Baquero F., et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11 (2005) 821-828
41. Menichetti F. Current and emerging serious Gram-positive infections. Clin Microbiol Infect 11 Suppl 3 (2005) 22-28
42. Chang S., Sievert D.M., Hageman J.C., Boulton M.L., Tenover F.C., Downes F.P., et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 348 (2003) 1342-1347
43. Strausbaugh L.J., Siegel J.D., and Weinstein R.A. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 42 (2006) 828-835
44. Grundmann H., and Hellriegel B. Mathematical modelling: a tool for hospital infection control. Lancet Infect Dis 6 (2006) 39-45
45. Weber S.G., Huang S.S., Oriola S., Huskins W.C., Noskin G.A., Harriman K., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control 35 (2007) 73-85